Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML

Annals of Hematology

Volumn 89, Issue 5, 2010, Pages 459-467

  Koenecke, Christian ^a   Kümpers, Philipp ^a   Lukasz, Alexander ^a   Dammann, Elke ^a   Verhagen, Willem ^a   Göhring, Gudrun ^a   Buchholz, Stefanie ^a   Krauter, Jürgen ^a   Eder, Matthias ^a   Schlegelberger, Brigitte ^a   Ganser, Arnold ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute myeloid leukemia; Allogeneic stem cell transplantation; Angiopoietin; Biomarker; Relapse; Soluble Tie2

Indexed keywords

ANGIOPOIETIN RECEPTOR; ANGIOTENSIN II; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN SECRETION; ALLOTRANSPLANTATION; BLAST CELL CRISIS; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; VASCULAR ENDOTHELIUM;

ADULT; BLAST CRISIS; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, TIE-2; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 77950579604     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0869-5     Document Type: Article

References (52)

1. F Dazzi C Fozza 2007 Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment Best Pract Res Clin Haematol 20 311 327 10.1016/j.beha.2006.10.002 1:STN:280:DC%2BD2s3ktFSmuw%3D%3D 17448964 (Pubitemid 46585972)
2. AH Elmaagacli DW Beelen G Trenn O Schmidt M Nahler UW Schaefer 1999 Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation Bone Marrow Transplant 23 771 777 10.1038/sj.bmt.1701672 1:STN:280:DyaK1M3ks1Wluw%3D%3D 10231138
3. C Schmid M Schleuning G Ledderose J Tischer HJ Kolb 2005 Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome J Clin Oncol 23 5675 5687 10.1200/JCO.2005.07.061 16110027
4. RF Schlenk K Dohner J Krauter S Frohling A Corbacioglu L Bullinger M Habdank D Spath M Morgan A Benner B Schlegelberger G Heil A Ganser H Dohner 2008 Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia N Engl J Med 358 1909 1918 10.1056/NEJMoa074306 1:CAS:528: DC%2BD1cXlt1Ggu70%3D 18450602 (Pubitemid 351620111)
5. D Grimwade H Walker F Oliver K Wheatley C Harrison G Harrison J Rees I Hann R Stevens A Burnett A Goldstone 1998 The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 92 2322 2333 1:CAS:528:DyaK1cXmsVKnsrw%3D 9746770
6. WJ Edenfield SD Gore 1999 Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemia Semin Oncol 26 21 34 1:STN:280:DyaK1M7ntFGltQ%3D%3D 10073559
7. EH Estey 2000 Treatment of relapsed and refractory acute myelogenous leukemia Leukemia 14 476 479 10.1038/sj.leu.2401568 1:CAS:528: DC%2BD3cXit1akt7w%3D 10720145
8. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364 10.1016/S0092-8674(00) 80108-7 1:CAS:528:DyaK28XltVSks7s%3D 8756718 (Pubitemid 26272076)
9. SV Rajkumar RA Mesa A Tefferi 2002 A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies J Hematother Stem Cell Res 11 33 47 10.1089/152581602753448522 1:CAS:528:DC%2BD38XhvFOitbw%3D 11847002 (Pubitemid 34163769)
10. WW Li M Hutnik G Gehr 2008 Antiangiogenesis in haematological malignancies Br J Haematol 143 622 631 10.1111/j.1365-2141.2008.07372.x 19036013
11. RM Mesters 2002 Angiogenesis in hematologic malignancies Ann Hematol 81 Suppl 2 S72 S74 12611085
12. S Loges G Heil M Bruweleit V Schoder M Butzal U Fischer UM Gehling G Schuch DK Hossfeld W Fiedler 2005 Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival J Clin Oncol 23 1109 1117 10.1200/JCO.2005.05.058 1:CAS:528:DC%2BD2MXitl2gtbg%3D 15718307 (Pubitemid 46202266)
13. R Bieker T Padro J Kramer M Steins T Kessler S Retzlaff F Herrera J Kienast WE Berdel RM Mesters 2003 Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia Cancer Res 63 7241 7246 1:CAS:528:DC%2BD3sXovVGltrg%3D 14612519
14. NP Brindle P Saharinen K Alitalo 2006 Signaling and functions of angiopoietin-1 in vascular protection Circ Res 98 1014 1023 10.1161/01.RES. 0000218275.54089.12 1:CAS:528:DC%2BD28Xjs1Kltrw%3D 16645151
15. U Fiedler T Krissl S Koidl C Weiss T Koblizek U Deutsch G Martiny-Baron D Marme HG Augustin 2003 Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats J Biol Chem 278 1721 1727 10.1074/jbc.M208550200 1:CAS:528:DC%2BD3sXisFyntQ%3D%3D 12427764 (Pubitemid 36801406)
16. S Wakui K Yokoo T Muto Y Suzuki H Takahashi M Furusato H Hano H Endou Y Kanai 2006 Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis Lab Invest 86 1172 1184 1:CAS:528:DC%2BD28XhtFShtrvJ 16969369
17. AL Wong ZA Haroon S Werner MW Dewhirst CS Greenberg KG Peters 1997 Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues Circ Res 81 567 574 1:CAS:528:DyaK2sXmsVCrt7c%3D 9314838
18. HG Augustin GY Koh G Thurston K Alitalo 2009 Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system Nat Rev Mol Cell Biol 10 165 177 10.1038/nrm2639 1:CAS:528:DC%2BD1MXitFKlu74%3D 19234476
19. NP Fam S Verma M Kutryk DJ Stewart 2003 Clinician guide to angiogenesis Circulation 108 2613 2618 10.1161/01.CIR.0000102939.04279.75 14638526 (Pubitemid 37466800)
20. HJ Kwak SJ Lee YH Lee CH Ryu KN Koh HY Choi GY Koh 2000 Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells Circulation 101 2317 2324 1:CAS:528:DC%2BD3cXjvFSrtbk%3D 10811601
21. AI Nykanen R Krebs A Saaristo P Turunen K Alitalo S Yla-Herttuala PK Koskinen KB Lemstrom 2003 Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis Circulation 107 1308 1314 10.1161/01.CIR.0000054623.35669.3F 12628953 (Pubitemid 36314416)
22. B Witzenbichler D Westermann S Knueppel HP Schultheiss C Tschope 2005 Protective role of angiopoietin-1 in endotoxic shock Circulation 111 97 105 10.1161/01.CIR.0000151287.08202.8E 1:CAS:528:DC%2BD2cXhtFeisLrO 15611372 (Pubitemid 40070850)
23. M van Meurs P Kumpers JJ Ligtenberg JH Meertens G Molema JG Zijlstra 2009 Bench-to-bedside review: angiopoietin signalling in critical illness-a future target? Crit Care 13 207 10.1186/cc7153 19435476
24. U Fiedler M Scharpfenecker S Koidl A Hegen V Grunow JM Schmidt W Kriz G Thurston HG Augustin 2004 The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies Blood 103 4150 4156 10.1182/blood-2003-10-3685 1:CAS:528:DC%2BD2cXkvVyitrc%3D 14976056 (Pubitemid 38685356)
25. SJ Mandriota C Pyke C Di Sanza P Quinodoz B Pittet MS Pepper 2000 Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia Am J Pathol 156 2077 2089 1:CAS:528:DC%2BD3cXksFSru7k%3D 10854229
26. P Pichiule JC Chavez JC LaManna 2004 Hypoxic regulation of angiopoietin-2 expression in endothelial cells J Biol Chem 279 12171 12180 10.1074/jbc.M305146200 1:CAS:528:DC%2BD2cXitl2hu7w%3D 14702352 (Pubitemid 38445782)
27. P Vajkoczy M Farhadi A Gaumann R Heidenreich R Erber A Wunder JC Tonn MD Menger G Breier 2002 Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 J Clin Invest 109 777 785 1:CAS:528:DC%2BD38Xit1Gnsrw%3D 11901186
28. F Tanaka S Ishikawa K Yanagihara R Miyahara Y Kawano M Li Y Otake H Wada 2002 Expression of angiopoietins and its clinical significance in non-small cell lung cancer Cancer Res 62 7124 7129 1:CAS:528:DC%2BD38XpsVaht78%3D 12460935 (Pubitemid 35424109)
29. C Sfiligoi A de Luca I Cascone V Sorbello L Fuso R Ponzone N Biglia E Audero R Arisio F Bussolino P Sismondi M De Bortoli 2003 Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival Int J Cancer 103 466 474 10.1002/ijc.10851 1:CAS:528: DC%2BD3sXhvVOjuw%3D%3D 12478661 (Pubitemid 36020220)
30. C Schliemann R Bieker N Thoennissen J Gerss R Liersch T Kessler T Buchner WE Berdel RM Mesters 2007 Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia Leukemia 21 1901 1906 10.1038/sj.leu.2404820 1:CAS:528:DC%2BD2sXptlSrs7c%3D 17597808 (Pubitemid 47299962)
31. CY Lee HF Tien CY Hu WC Chou LI Lin 2007 Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia Br J Cancer 97 877 882 1:CAS:528:DC%2BD2sXhtFSnurbJ 17848952
32. P Kumpers C Koenecke H Hecker J Hellpap R Horn W Verhagen S Buchholz B Hertenstein J Krauter M Eder S David G Gohring H Haller A Ganser 2008 Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies Blood 112 2139 2148 10.1182/blood-2007-12-130021 18483397
33. T Mammoto SM Parikh A Mammoto D Gallagher B Chan G Mostoslavsky DE Ingber VP Sukhatme 2007 Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo J Biol Chem 282 23910 23918 10.1074/jbc.M702169200 1:CAS:528:DC%2BD2sXoslOnt7w%3D 17562701 (Pubitemid 47328051)
34. F Roviezzo S Tsigkos A Kotanidou M Bucci V Brancaleone G Cirino A Papapetropoulos 2005 Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage J Pharmacol Exp Ther 314 738 744 10.1124/jpet.105.086553 1:CAS:528:DC%2BD2MXntVSisLw%3D 15870388 (Pubitemid 41043857)
35. HT Yuan EV Khankin SA Karumanchi SM Parikh 2009 Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium Mol Cell Biol 29 2011 2022 10.1128/MCB.01472-08 1:CAS:528:DC%2BD1MXks1Sku7c%3D 19223473
36. CM Findley MJ Cudmore A Ahmed CD Kontos 2007 VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling Arterioscler Thromb Vasc Biol 27 2619 2626 10.1161/ATVBAHA.107.150482 1:CAS:528:DC%2BD2sXhtlahtLrN 17901375 (Pubitemid 350158914)
37. P Reusch B Barleon K Weindel G Martiny-Baron A Godde G Siemeister D Marme 2001 Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood Angiogenesis 4 123 131 10.1023/A:1012226627813 1:CAS:528:DC%2BD38XovV2nug%3D%3D 11806244 (Pubitemid 34032698)
38. KG Peters CD Kontos PC Lin AL Wong P Rao L Huang MW Dewhirst S Sankar 2004 Functional significance of Tie2 signaling in the adult vasculature Recent Prog Horm Res 59 51 71 10.1210/rp.59.1.51 1:CAS:528:DC%2BD2cXisFKht7w%3D 14749497
39. V Martin D Liu J Fueyo C Gomez-Manzano 2008 Tie2: a journey from normal angiogenesis to cancer and beyond Histol Histopathol 23 773 780 1:CAS:528:DC%2BD1cXlslWktb4%3D 18366015
40. AL Harris P Reusch B Barleon C Hang N Dobbs D Marme 2001 Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy Clin Cancer Res 7 1992 1997 1:CAS:528: DC%2BD3MXlslalurg%3D 11448916
41. ML Slovak KJ Kopecky PA Cassileth DH Harrington KS Theil A Mohamed E Paietta CL Willman DR Head JM Rowe SJ Forman FR Appelbaum 2000 Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study Blood 96 4075 4083 1:CAS:528:DC%2BD3cXosl2hsbo%3D 11110676
42. T Iwai S Yokota M Nakao T Okamoto M Taniwaki N Onodera A Watanabe A Kikuta A Tanaka K Asami I Sekine H Mugishima Y Nishimura S Koizumi Y Horikoshi J Mimaya S Ohta K Nishikawa A Iwai T Shimokawa M Nakayama K Kawakami T Gushiken N Hyakuna T Fujimoto, et al. 1999 Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan Leukemia 13 38 43 10.1038/sj/leu/2401241 1:CAS:528:DyaK1MXht1GnurY%3D 10049058
43. H Kiyoi T Naoe Y Nakano S Yokota S Minami S Miyawaki N Asou K Kuriyama I Jinnai C Shimazaki H Akiyama K Saito H Oh T Motoji E Omoto H Saito R Ohno R Ueda 1999 Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia Blood 93 3074 3080 1:CAS:528:DyaK1MXivVyltbg%3D 10216104
44. P Nasarre M Thomas K Kruse I Helfrich V Wolter C Deppermann D Schadendorf G Thurston U Fiedler HG Augustin 2009 Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth Cancer Res 69 4 1324 1333 10.1158/0008-5472.CAN-08-3030 1:CAS:528:DC%2BD1MXhslynsro%3D 19208839
45. HA Hou WC Chou LI Lin JL Tang MH Tseng CF Huang M Yao CY Chen W Tsay HF Tien 2008 Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia Leuk Res 32 904 912 10.1016/j.leukres.2007.08.010 1:CAS:528:DC%2BD1cXjs1SltrY%3D 17904634 (Pubitemid 351392041)
46. C Schliemann R Bieker T Padro T Kessler H Hintelmann T Buchner WE Berdel RM Mesters 2006 Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia Haematologica 91 1203 1211 1:CAS:528:DC%2BD28XhtVOhtL%2FK 16956819
47. CR Tait PF Jones 2004 Angiopoietins in tumours: the angiogenic switch J Pathol 204 1 10 10.1002/path.1618 1:CAS:528:DC%2BD2cXot1alsLo%3D 15307132 (Pubitemid 39214476)
48. van der Heijden M, van Nieuw Amerongen GP, van Hinsbergh VW, Groeneveld AJ (2009) The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and non-septic critically ill patients. Shock (in press). doi: 10.1097/SHK.0b013e3181b2f978
49. P Kumpers A Lukasz S David R Horn C Hafer R Faulhaber-Walter D Fliser H Haller JT Kielstein 2008 Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients Crit Care 12 R147 10.1186/cc7130 19025590
50. DC Gallagher RS Bhatt SM Parikh P Patel V Seery DF McDermott MB Atkins VP Sukhatme 2007 Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak Clin Cancer Res 13 2115 2120 10.1158/1078-0432.CCR-06- 2509 1:CAS:528:DC%2BD2sXjs12rt7s%3D 17404094 (Pubitemid 46649880)
51. P Kumpers J Hellpap S David R Horn H Leitolf H Haller M Haubitz 2009 Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement Nephrol Dial Transplant 24 6 1845 1850 10.1093/ndt/gfn755 19164323
52. RS Herbst D Hong L Chap R Kurzrock E Jackson JM Silverman E Rasmussen YN Sun D Zhong YC Hwang JL Evelhoch JD Oliner N Le LS Rosen 2009 Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors J Clin Oncol 27 21 3557 65 10.1200/JCO.2008.19.6683 1:CAS:528:DC%2BD1MXhtVSqtLjK 19546406